18195-Esophageal Cancer-NA-580

Esophageal Cancer

CA209-577 - A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects with Resected Esophageal, or Gastroesophageal Junction Cancer

  • Details

ClinicalTrials.gov ID: NCT02743494
Diagnosis Type: NA
USOR Number: 18195

  • Address

2070 W Rudasill Rd, Suite 130
Tucson, AZ 85704
P: (520) 797-4468

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.